Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes
Iglika Djoumerska‐Alexieva(Bulgarian Academy of Sciences), Tchavdar L. Vassilev(Bulgarian Academy of Sciences), Z Stefanova(Bulgarian Academy of Sciences), Clemens L. Bockmeyer(Medizinische Hochschule Hannover), Ralf A. Claus(Friedrich Schiller University Jena), Sandro Lindig(Friedrich Schiller University Jena), Lubka T. Roumenina(Université Paris Cité), Maya Hadzhieva(Bulgarian Academy of Sciences), Jean‐Marc Cavaillon(Institut Pasteur), Michael Bauer(Jena University Hospital), Catherine Fitting(Institut Pasteur), Jordan D. Dimitrov(Inserm), Elisaveta Voynova(National Institutes of Health), Petya Dimitrova(Bulgarian Academy of Sciences), Nina Ivanovska(Bulgarian Academy of Sciences), Srini V. Kaveri(Centre National de la Recherche Scientifique), Stephan von Gunten(University of Bern), Markus Bläss(Friedrich Schiller University Jena), Anastas Pashov(Bulgarian Academy of Sciences)
Cited by 19
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Complement System Part I – Molecular Mechanisms of Activation and Regulation
|Frontiers in Immunology|2015|1.5k
Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome
|Circulation|2002|1k
Dysregulation of in vitro cytokine production by monocytes during sepsis.
|Journal of Clinical Investigation|1991|765